Short-Term Corticosteroid Therapy for Early Exacerbation of COVID-19 Pneumonia: A Case Report

Akira Urano; Hajime Kasai; Yushi Murai; Hideki Ikeda; Takashi Urushibara

doi:10.12659/AJCR.924476

14 August 2020: Articles

Short-Term Corticosteroid Therapy for Early Exacerbation of COVID-19 Pneumonia: A Case Report

Management of emergency care

Akira Urano ^A , Hajime Kasai ^B* , Yushi Murai ^B , Hideki Ikeda ^B , Takashi Urushibara ^A

DOI: 10.12659/AJCR.924476

Am J Case Rep 2020; 21:e924476

Authors information Article notes Copyright and License information

View HTML version

Figure 1. Clinical course of the patient. Chest X-rays revealed worsening diffuse infiltrates (arrow) before systemic corticosteroid therapy. After administration of systemic corticosteroid therapy on days 5–7, chest X-ray images and SpO2 levels displayed immediate and sustained improvement. SpO2 – oxygen saturation; BT – body temperature.

Back to the Article

Short-Term Corticosteroid Therapy for Early Exacerbation of COVID-19 Pneumonia: A Case Report

Your Privacy